6月30日，A股最"上头"的板块是谁？非脑机接口莫属！ 在科技狂人马斯克的带动下，相关概念股集体起飞。 截至收盘，翔宇医疗（688626.SH）涨20%，爱朋医疗（300753.SZ）涨超10%，创新医疗（002173.SZ）涨10%，三博脑科（301293.SZ）、南京熊猫 （600775.SH）、熵基科技（301330.SZ）大涨。 消息面，马斯克旗下脑机接口公司Neuralink发布了一段长达一小时的视频，展示了他们最新的研究成果及产品发展方向。据介绍，目前Neuralink的受试者已 经达到7人，其中涵盖4名脊髓损伤患者与3名肌萎缩侧索硬化症（ALS）患者，受试者们平均每周使用设备时长约50小时，峰值超100小时，几乎只要是清醒 的时间都在用。 不仅如此，Neuralink还公布了未来的发展路线图—— 2025年底：在言语皮层植入设备，解码无声"意图言语"，即直接从大脑信号中解码有意识的词语，转换为语音； 据Precedence Research统计数据，2024年全球脑机接口市场规模为26.2亿美元，预计到2034年将增加到约124亿美元，复合年增长率达17.35%，在医疗、娱 乐、智能家居、军事等 ...

Group 1: Industry Overview - Brain-computer interface (BCI) technology is advancing rapidly due to breakthroughs in artificial intelligence, neuroscience, and sensing technologies [1] - The Sichuan Provincial Economic and Information Technology Department has launched a plan to develop BCI products, aiming to complete the R&D of 3 invasive and 5 non-invasive BCI products by 2027 [1] - The plan also targets to serve over 50,000 medical patients annually by 2027 and to establish Sichuan as a national leader in BCI and human-computer interaction by 2030 [1] Group 2: Non-Invasive BCI Applications - Non-invasive BCI technology is expected to significantly improve the early diagnosis and treatment efficiency of Alzheimer's disease [2] - The technology aims to manage chronic diseases in the elderly through early screening and outpatient rehabilitation [2] - A project named "Swan Lake" has been developed for community-based early screening and non-drug interventions for mild cognitive impairment (MCI) [2][3] Group 3: Research Findings - Research involving over 3,000 elderly participants has shown that MCI patients exhibit abnormal frequency bands and network patterns [3] - Non-invasive BCI screening can achieve over 90% sensitivity using just 4 electrodes in a 5-10 minute test, enhancing the efficiency of MCI screening [3] - Non-invasive BCI techniques like transcranial magnetic stimulation (TMS) and transcranial electrical stimulation (TES) are being explored for outpatient rehabilitation of MCI [3] Group 4: Invasive BCI Innovations - Invasive BCI technology has achieved a breakthrough in the surgical treatment of gliomas, marking a significant advancement in neurosurgery [5][6] - The technology allows for real-time analysis of brain signals to differentiate tumor tissue from normal brain tissue, improving tumor resection rates [6] - The first successful application of invasive BCI technology for glioma surgery in China has been reported, showcasing its potential to enhance surgical outcomes [6][7] Group 5: Future Prospects - Invasive BCI technology not only maximizes safe tumor removal but also predicts tumor recurrence, potentially extending patient survival [7] - The industry is awaiting the development of mature products and technologies that could lead to transformative changes in medical practices [7]

近期，脑机接口方向值得关注，5月17日，首都医科大学附属北京天坛医院脑机接口临床与转化病房揭牌成 立，该病房由北京天坛医院牵头，联合国内多家科研单位共建，未来将围绕脑机接口开展科研攻关、临床试 验，并推动相关科技成果转化，实现脑机接口技术发展从"科研驱动"向"临床牵引"迈进。据悉，这也是国内 第一个将脑机接口技术应用于临床的病房，东吴证券表示，侵入式技术持续突破，将推动消费和医疗康复市 场提升对脑机接口技术认知，2025年有望持续突破，非侵入式脑机接口产品商业化落地有望加速。 后市观点 长江证券资深投资顾问刘浪认为，回顾上周行情，市场延续震荡调整格局，量能始终未能有效放大，上周整 体维持在1万亿附近。值得注意的是，三大指数均缩量跌破5日线，原本震荡向上的结构遭到破坏，后续重新 放量站上5日线是关注重点。与此同时，近期市场高位抱团较为明显，若能走出具有足够延续性的新主线， 资金大概率会选择进行高低切。宏观面上，可重点关注以下事项： 并购重组方面：5月16日，证监会发布修改后的《上市公司重大资产重组管理办法》，建立重组股份对价分 期支付机制，提高对财务状况变化、同业竞争和关联交易监管的包容度，对私募投资基金投资期 ...

Table_First|Table_Summary 华福证券 固定收益专题 2025 年 5 月 8 日 分析师: 徐亮 执业证书编号： S0210524040003 邮箱： xl30484@hfzq.com.cn Table_First|Table_Contacter 分析师: 林浩睿 执业证书编号： S0210524070001 邮箱： lhr30501@hfzq.com.cn 联系人: 黄涵静 邮箱： hhj30695@hfzq.com.cn 相关报告 1.《科创债怎么看？》2025.5.7 2.《怎么看一揽子货币政策及对债市的影 响》2025.5.7 固 定 收 益 专 题 证 券 研 究 报 诚信专业 发现价值 请务必阅读报告末页的重要声明 热门题材转债配置指南 投资要点： 团队成员 e p y T t r o 1 Table_First p e R _ e l b a T | t s r 告 Table_First|Table_Author lhr30501@hfzq i F _ e l b a T 固 收 研 究 Table_First|Table_RelateReport ➢ 当前市场背景下， ...